Illinois Municipal Retirement Fund Sells 393 Shares of Integer Holdings Co. (NYSE:ITGR)

Illinois Municipal Retirement Fund trimmed its holdings in Integer Holdings Co. (NYSE:ITGR) by 2.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,778 shares of the medical equipment provider’s stock after selling 393 shares during the quarter. Illinois Municipal Retirement Fund owned about 0.05% of Integer worth $2,356,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ITGR. Mather Group LLC. raised its stake in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares during the last quarter. Huntington National Bank increased its holdings in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 268 shares in the last quarter. R Squared Ltd bought a new position in Integer in the 4th quarter worth approximately $44,000. Versant Capital Management Inc lifted its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares in the last quarter. Finally, Principal Securities Inc. boosted its position in Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 152 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Benchmark boosted their price objective on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, February 21st. Citigroup raised their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. KeyCorp boosted their price target on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Truist Financial increased their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Integer has an average rating of “Moderate Buy” and an average target price of $147.67.

Integer Stock Down 1.8 %

Shares of NYSE ITGR opened at $124.00 on Friday. Integer Holdings Co. has a 52-week low of $105.14 and a 52-week high of $146.36. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The stock has a market cap of $4.17 billion, a P/E ratio of 36.91, a P/E/G ratio of 1.72 and a beta of 1.13. The firm has a 50 day moving average price of $137.06 and a 200 day moving average price of $132.78.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Analysts expect that Integer Holdings Co. will post 6.01 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.